Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for non-invasive drug delivery methods
3.2.1.2 Advancements in buccal drug delivery technologies
3.2.1.3 Rising prevalence of chronic diseases requiring long-term medication
3.2.1.4 Growing awareness and acceptance of buccal drug delivery systems
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited market acceptance due to patient discomfort
3.2.2.2 High development and production costs
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Future market trends
3.6 Regulatory landscape
3.7 Technological landscape
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Buccal tablets
5.3 Buccal films
5.4 Buccal gels
5.5 Buccal sprays
5.6 Buccal patches
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Pain management
6.3 Hormone replacement
6.4 Cardiovascular diseases
6.5 Neurological disorders
6.6 Respiratory disorders
6.7 Addiction treatment
6.8 Mental health disorders
Chapter 7 Market Estimates and Forecast, By System Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Matrix systems
7.3 Reservoir systems
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Homecare settings
8.4 Specialty clinics
8.5 Ambulatory surgical centers
8.6 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AbbVie Inc.
10.2 Amgen Inc.
10.3 Collegium Pharmaceutical, Inc.
10.4 Endo International plc
10.5 Galderma SA
10.6 Indivior plc
10.7 Johnson & Johnson Services, Inc.
10.8 Kyowa Kirin Co., Ltd.
10.9 Mallinckrodt plc
10.10 Neurelis, Inc.
10.11 Novartis AG
10.12 Pfizer Inc.
10.13 Sanofi
10.14 Takeda Pharmaceuticals Company Limited
10.15 Teva Pharmaceutical Industries Ltd.
